Cerebral Therapeutics Raises Series A Extension Financing to Advance Clinical-Stage Drug Device Combination Therapy to Phase 3 Readiness for Adult Refractory Epilepsy

Financing Led by Granite Point Capital and Vivo Capital Cerebral Therapeutics Prepares IND and Clinical Development Program in the U.S. AURORA, Colo., March 8, 2019 -- (Healthcare Sales & Marketing Network) -- Cerebral Therapeutics, a clinical stage... Biopharmaceuticals, Drug Delivery, Venture Capital Cerebral Therapeutics, epilepsy, reformulated medications, implantable infusion
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news